Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
Clinical trial NCT00601003 · COMPLETED
Trial details
- NCT number
- NCT00601003
- Sponsor
- Giselle Sholler
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-14
- Primary completion
- 2020-04-28
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.